Registered Nurse in Bosque Farms, NM Accepting Medicare
4 Registered Nurse nurses found. Showing 1 - 4
 Terry Henson, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 455 Sego Lily St, Bosque Farms, NM 87068 Phone: 505-884-1214 Fax: 505-884-8046 |
Jacqueline Kelly-romero, RN, MSN, CCM Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1390 W. Bosque Lp, Bosque Farms, NM 87068 Phone: 505-869-2646 |
Tanya Gonzales, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1575 West Bosque Looop, Bosque Farms, NM 87068 Phone: 505-459-8143 |
Pamela Fisher, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 715 Calle Del Sol, Bosque Farms, NM 87068 Phone: 505-730-6228 |
News Archive
Tricks and illusions help unveil how the brain processes multiple sensory inputs
Tricks and illusions, once the domain of magicians, are helping scientists unveil how the brain works.
Implementation roundup: HHS meets on state exchanges; Regs out soon on 'unreasonable' insurance rate increases; Plan 'B' options for the individual mandate
The first of a two-day, closed-door, HHS meeting with representatives from 44 states suggested that in many cases states will delay passing laws to create health insurance exchanges until 2012, according to one attendee. ... States have flexibility under the law to structure exchanges in different ways. HHS has urged that, if possible, they begin passing legislation in 2011 to get that process underway (Reichard, 12/16).
Research Roundup: The cost of medical errors; 'Unreasonable rate increases'
Health Affairs: The $17.1 Billion Problem: The Annual Cost Of Measurable Medical Errors - "The estimated total cost of measurable medical errors in the United States was $17.1 billion in 2008, which was 0.72 percent of the $2.391 trillion spent on health care," write the authors of this study that used an "an actuarial approach to measure the frequency and costs of measurable U.S. medical errors, identified through medical claims data."
Pfizer to present results of hemophilia studies at WFH 2010 Congress
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
› Verified 5 days ago